(Q45411579)

English

Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens

scientific article published on 2 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens (English)

1 reference

Europe PubMed Central

14 December 2017

vector-borne disease

0 references

Semliki Forest virus

0 references

tobacco mosaic virus

object named as

Tobacco mosaic virus

1 reference

based on heuristic

inferred from title

author name string

Mark L Smith

1

1 reference

Europe PubMed Central

14 December 2017

Tina Corbo

2

1 reference

Europe PubMed Central

14 December 2017

Jacqueline Bernales

3

1 reference

Europe PubMed Central

14 December 2017

John A Lindbo

4

1 reference

Europe PubMed Central

14 December 2017

Gregory P Pogue

5

1 reference

Europe PubMed Central

14 December 2017

Kenneth E Palmer

6

1 reference

Europe PubMed Central

14 December 2017

Alison A McCormick

7

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

2 October 2006

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

358

1 reference

Europe PubMed Central

14 December 2017

2

1 reference

Europe PubMed Central

14 December 2017

321-333

1 reference

Europe PubMed Central

14 December 2017

Efficient accommodation of recombinant, foot-and-mouth disease virus RGD peptides to cell-surface integrins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Semliki Forest virus expression system: production of conditionally infectious recombinant particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Self-assembly of tobacco mosaic virus: the role of an intermediate aggregate in generating both specificity and speed

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

cDNA cloning of the complete genome of tobacco mosaic virus and production of infectious transcripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Structures and roles of the polymorphic forms of tobacco mosaic virus protein. I. Sedimentation studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Degradation of tobacco mosaic virus with acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Reconstitution of tobacco mosaic virus. III. Improved methods and the use of mixed nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Biochemical engineering approaches to the challenges of producing pure plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Comparative immunogenicities of tobacco mosaic virus, protein subunits, and reaggregated protein subunits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Biology and application of alphaviruses in gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Nonviral vectors in the new millennium: delivery barriers in gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Clinical experience with respiratory syncytial virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Making an ally from an enemy: plant virology and the new agriculture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Exact prediction of a natural T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Partial reconstitution of tobacco mosaic virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

The tobacco mosaic virus assembly origin RNA. Functional characteristics defined by directed mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Cancer therapy using a self-replicating RNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Self-replicating Semliki Forest virus RNA as recombinant vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

Assembly of the particle of tobacco mosaic virus from RNA and disks of protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymerization of tobacco mosaic virus protein and its control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.040

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.08.040

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45411579&oldid=2076840997"